Medicamen Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

172.39

137.88

115.45

110.15

117.34

Operating profit

25.97

24.15

23.56

19.58

17.76

Interest

4.38

2.92

1.40

1.06

0.57

Gross profit

23.90

23.69

23.87

19.27

19.10

EPS (Rs)

10.46

11.86

12.20

10.22

10.03

Other income

2.30

2.46

1.72

0.75

1.91

Stock adjustment

-13.32

-10.30

-3.34

1.04

-1.53

Raw material

104.70

81.80

55.69

65.84

74.49

Power and fuel

-

-

-

-

-

Employee expenses

22.12

18.57

14.50

8.79

9.29

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

32.92

23.66

25.03

14.90

17.33

Provisions made

-

-

-

-

-

Depreciation

7.01

6.35

5.77

2.52

2.50

Taxation

3.59

2.33

3.20

4.26

4.34

Net profit / loss

13.30

15.00

14.91

12.49

12.26

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

12.71

12.65

12.22

12.22

12.22

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

15.07

17.51

20.40

17.78

15.14

GPM (%)

13.68

16.88

20.38

17.38

16.02

NPM (%)

7.61

10.69

12.72

11.26

10.28